<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35437639</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-2218</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Surgical endoscopy</Title>
          <ISOAbbreviation>Surg Endosc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Efficacy and safety of endoscopic pyloric balloon dilation in patients with refractory gastroparesis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-022-09230-w</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">There has been interest in the use of pyloric therapies for the treatment of refractory gastroparesis. However, data on endoscopic pyloric dilation are scarce. We aimed to assess the efficacy and safety of this procedure in refractory gastroparesis.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We performed a retrospective analysis of 47 patients referred for refractory gastroparesis, confirmed by gastric emptying scintigraphy, and treated with endoscopic pyloric through-the-scope balloon dilation. The primary endpoint was the effectiveness of the procedure, evaluated with the Gastric Cardinal Symptom Index (GCSI) at 2 and 6 months.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A clinical response, defined by a 1.0 point decrease in the GCSI score, was observed in 25 patients at 2 months (53%) and in 19 patients at 6 months (40%). The mean GCSI score decreased significantly at 2 and 6 months compared to the preoperative score (3.9 ± 0.87 vs 2.3 ± 1.37 and 3.9 ± 0.87 vs 2.9 ± 1.27, respectively; p &lt; 0.0001). No complication was observed. Nine patients had a delayed relapse at 1 year. A second dilation was performed for eight patients and it was effective in five of them (63%). The mean follow-up time of the patients was 27.0 ± 10.4 months. At 2 years, 15 patients still experienced improvement following this treatment (32%). No predictive factor of clinical response was identified.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The efficacy of pyloric dilation is 53% at 2 months, with sustained improvement in one third of patients at 2 years. This treatment should be considered as an alternative option to pyloromyotomy.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Soliman</LastName>
            <ForeName>Heithem</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0003-1644-7272</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche Sur L'Inflammation, Université de Paris Cité, Inserm UMRS 1149, 75018, Paris, France. heithemsoliman90@hotmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France. heithemsoliman90@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Oiknine</LastName>
            <ForeName>Elsa</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cohen-Sors</LastName>
            <ForeName>Boris</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moszkowicz</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Chirurgie Générale Et Digestive, AP-HP, Hôpital Louis Mourier, DMU ESPRIT-GHU AP-HP, Nord-Université de Paris, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gorbatchef</LastName>
            <ForeName>Caroline</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dior</LastName>
            <ForeName>Marie</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nebunu</LastName>
            <ForeName>Nicoleta</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le Gall</LastName>
            <ForeName>Maude</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche Sur L'Inflammation, Université de Paris Cité, Inserm UMRS 1149, 75018, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Coffin</LastName>
            <ForeName>Benoit</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche Sur L'Inflammation, Université de Paris Cité, Inserm UMRS 1149, 75018, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duboc</LastName>
            <ForeName>Henri</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Recherche Sur L'Inflammation, Université de Paris Cité, Inserm UMRS 1149, 75018, Paris, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hépato Gastro Entérologie, Hôpital Louis Mourier, DMU ESPRIT - GHU (AP-HP), 178 rue des Renouillers, 92700, Colombes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Surg Endosc</MedlineTA>
        <NlmUniqueID>8806653</NlmUniqueID>
        <ISSNLinking>0930-2794</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Delayed gastric emptying</Keyword>
        <Keyword MajorTopicYN="N">Endoscopic treatment</Keyword>
        <Keyword MajorTopicYN="N">Pyloric dilation</Keyword>
        <Keyword MajorTopicYN="N">Vomiting</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35437639</ArticleId>
        <ArticleId IdType="doi">10.1007/s00464-022-09230-w</ArticleId>
        <ArticleId IdType="pii">10.1007/s00464-022-09230-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rey E, Choung RS, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR (2012) Prevalence of hidden gastroparesis in the community: the gastroparesis “Iceberg.” J Neurogastroenterol Motil 18:34–42. https://doi.org/10.5056/jnm.2012.18.1.34</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5056/jnm.2012.18.1.34</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu D, Ramsey FV, Norton WF, Norton N, Schneck S, Gaetano T, Parkman HP (2017) The burdens, concerns, and quality of life of patients with gastroparesis. Dig Dis Sci 62:879–893. https://doi.org/10.1007/s10620-017-4456-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-017-4456-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW (1998) Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 43:2398–2404. https://doi.org/10.1023/a:1026665728213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/a:1026665728213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR (1985) Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 249:G580-585. https://doi.org/10.1152/ajpgi.1985.249.5.G580</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.1985.249.5.G580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camilleri M, Brown ML, Malagelada JR (1986) Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 91:94–99. https://doi.org/10.1016/0016-5085(86)90444-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0016-5085(86)90444-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mearin F, Camilleri M, Malagelada JR (1986) Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 90:1919–1925. https://doi.org/10.1016/0016-5085(86)90262-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0016-5085(86)90262-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gourcerol G, Tissier F, Melchior C, Touchais JY, Huet E, Prevost G, Leroi AM, Ducrotte P (2015) Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther 41:360–367. https://doi.org/10.1111/apt.13053</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.13053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L (2013) Clinical guideline: management of gastroparesis. Am J Gastroenterol 108:18–38. https://doi.org/10.1038/ajg.2012.373</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2012.373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erbas T, Varoglu E, Erbas B, Tastekin G, Akalin S (1993) Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 16:1511–1514. https://doi.org/10.2337/diacare.16.11.1511</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.16.11.1511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ducrotte P, Coffin B, Bonaz B, Fontaine S, Bruley Des Varannes S, Zerbib F, Caiazzo R, Grimaud JC, Mion F, Hadjadj S, Valensi PE, Vuitton L, Charpentier G, Ropert A, Altwegg R, Pouderoux P, Dorval E, Dapoigny M, Duboc H, Benhamou PY, Schmidt A, Donnadieu N, Gourcerol G, Guerci B, ENTERRA Research Group (2020) Gastric electrical stimulation reduces refractory vomiting in a randomized crossover trial. Gastroenterology 158:506–514. https://doi.org/10.1053/j.gastro.2019.10.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2019.10.018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB (2008) Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 103:416–423. https://doi.org/10.1111/j.1572-0241.2007.01676.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1572-0241.2007.01676.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arts J, Holvoet L, Caenepeel P, Bisschops R, Sifrim D, Verbeke K, Janssens J, Tack J (2007) Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 26:1251–1258. https://doi.org/10.1111/j.1365-2036.2007.03467.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2036.2007.03467.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez J, Strong AT, Haskins IN, Landreneau JP, Allemang MT, El-Hayek K, Villamere J, Tu C, Cline MS, Kroh M, Ponsky JL (2018) Per-oral Pyloromyotomy (POP) for medically refractory gastroparesis: short term results from the first 100 patients at a high volume center. Ann Surg 268:421–430. https://doi.org/10.1097/SLA.0000000000002927</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SLA.0000000000002927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ragi O, Jacques J, Branche J, Leblanc S, Vanbiervliet G, Legros R, Pioche M, Rivory J, Chaussade S, Barret M, Wallenhorst T, Barthet M, Kerever S, Gonzalez J-M (2020) One-year results of gastric peroral endoscopic myotomy for refractory gastroparesis: a French multicenter study. Endoscopy. https://doi.org/10.1055/a-1205-5686</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/a-1205-5686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jehangir A, Malik Z, Petrov RV, Parkman HP (2020) EndoFLIP and pyloric dilation for gastroparesis symptoms refractory to pyloromyotomy/pyloroplasty. Dig Dis Sci. https://doi.org/10.1007/s10620-020-06510-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-020-06510-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weusten BLAM, Barret M, Bredenoord AJ, Familiari P, Gonzalez J-M, van Hooft JE, Ishaq S, Lorenzo-Zúñiga V, Louis H, van Meer S, Neumann H, Pohl D, Prat F, von Renteln D, Savarino E, Sweis R, Tack J, Tutuian R, Martinek J (2020) Endoscopic management of gastrointestinal motility disorders—part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 52:498–515. https://doi.org/10.1055/a-1160-5549</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/a-1160-5549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine (2008) Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol 36:44–54. https://doi.org/10.2967/jnmt.107.048116</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2967/jnmt.107.048116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sachdeva P, Malhotra N, Pathikonda M, Khayyam U, Fisher RS, Maurer AH, Parkman HP (2011) Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci 56:1138–1146. https://doi.org/10.1007/s10620-011-1635-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-011-1635-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J (2004) Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 13:833–844. https://doi.org/10.1023/B:QURE.0000021689.86296.e4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/B:QURE.0000021689.86296.e4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasricha PJ, Camilleri M, Hasler WL, Parkman HP (2017) White paper AGA: gastroparesis: clinical and regulatory insights for clinical trials. Clin Gastroenterol Hepatol 15:1184–1190. https://doi.org/10.1016/j.cgh.2017.04.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2017.04.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray FR, Schindler V, Hente JM, Fischbach LM, Schnurre L, Deibel A, Hildenbrand FF, Tatu A, Pohl D (2021) Pyloric dilation with the eosophgeal functional lumen imaging probe in gastroparesis improves gastric emptying, pyloric distensibility, and symptoms. Gastrointest Endosc. https://doi.org/10.1016/j.gie.2021.03.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gie.2021.03.022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bae JH, Yang D-H, Lee S, Soh JS, Lee S, Lee H-S, Lee HJ, Park SH, Kim K-J, Ye BD, Myung S-J, Yang S-K, Byeon J-S (2016) Optimized hybrid endoscopic submucosal dissection for colorectal tumors: a randomized controlled trial. Gastrointest Endosc 83:584–592. https://doi.org/10.1016/j.gie.2015.06.057</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gie.2015.06.057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS (2002) Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 55:920–923. https://doi.org/10.1067/mge.2002.124739</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mge.2002.124739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coleski R, Anderson MA, Hasler WL (2009) Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Dig Dis Sci 54:2634–2642. https://doi.org/10.1007/s10620-008-0660-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-008-0660-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camilleri M, Chedid V, Ford AC, Haruma K, Horowitz M, Jones KL, Low PA, Park S-Y, Parkman HP, Stanghellini V (2018) Gastroparesis. Nat Rev Dis Primers 4:41. https://doi.org/10.1038/s41572-018-0038-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41572-018-0038-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez JM, Benezech A, Vitton V, Barthet M (2017) G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 46:364–370. https://doi.org/10.1111/apt.14132</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.14132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vosoughi K, Ichkhanian Y, Benias P, Miller L, Aadam AA, Triggs JR, Law R, Hasler W, Bowers N, Chaves D, Ponte-Neto AM, Draganov P, Yang D, Halabi ME, Sanaei O, Gutierrez OIB, Bulat RS, Pandolfino J, Khashab M (2021) Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut. https://doi.org/10.1136/gutjnl-2020-322756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2020-322756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohan BP, Chandan S, Jha LK, Khan SR, Kotagiri R, Kassab LL, Ravikumar NPG, Bhogal N, Chandan OC, Bhat I, Hewlett AT, Jacques J, Ponnada S, Asokkumar R, Adler DG (2020) Clinical efficacy of gastric per-oral endoscopic myotomy (G-POEM) in the treatment of refractory gastroparesis and predictors of outcomes: a systematic review and meta-analysis using surgical pyloroplasty as a comparator group. Surg Endosc 34:3352–3367. https://doi.org/10.1007/s00464-019-07135-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00464-019-07135-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teitelbaum EN, Soper NJ, Pandolfino JE, Kahrilas PJ, Hirano I, Boris L, Nicodème F, Lin Z, Hungness ES (2015) Esophagogastric junction distensibility measurements during Heller myotomy and POEM for achalasia predict postoperative symptomatic outcomes. Surg Endosc 29:522–528. https://doi.org/10.1007/s00464-014-3733-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00464-014-3733-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desprez C, Melchior C, Wuestenberghs F, Zalar A, Jacques J, Leroi A-M, Gourcerol G (2019) Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection. Gastrointest Endosc 90:754-760.e1. https://doi.org/10.1016/j.gie.2019.04.228</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gie.2019.04.228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wellington J, Scott B, Kundu S, Stuart P, Koch KL (2017) Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis. Autonomic Neurosci 202:56–61. https://doi.org/10.1016/j.autneu.2016.07.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autneu.2016.07.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasricha PJ, Grover M, Yates KP, Abell TL, Bernard CE, Koch KL, McCallum RW, Sarosiek I, Kuo B, Bulat R, Chen J, Shulman R, Lee L, Tonascia J, Miriel LA, Hamilton F, Farrugia G, Parkman HP (2021) Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathological features. Gastroenterology. https://doi.org/10.1053/j.gastro.2021.01.230</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2021.01.230</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
